戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 solated tasks (e.g., walking, running, stair ambulation).
2 scale ranging from 0 (no mobilisation) to 4 (ambulation).
3 ith a subsequent positive effect on maternal ambulation.
4  calf hypertrophy and progressive decline in ambulation.
5 ntly, substantially reduce the likelihood of ambulation.
6 ) also predicted an increased probability of ambulation.
7 10 days followed by reloading through normal ambulation.
8 tis is associated with increased load during ambulation.
9 593 activity events, of which 249 (42%) were ambulation.
10 lcerations, relieves rest pain, and improves ambulation.
11 evere phenotype of classical UCMD precluding ambulation.
12  weight heparin in obese patients, and early ambulation.
13 10 days followed by reloading through normal ambulation.
14  activity that limited the amount of forward ambulation.
15 rom focused stereotypy toward an increase in ambulation.
16  psychotropic drug use, and transferring and ambulation.
17 ce the HPC theta rhythm during REM sleep and ambulation.
18  activity that limited the amount of forward ambulation.
19 ted dystonia and/or spasticity with impaired ambulation.
20 muscle fatigue resistance and increases cage ambulation.
21 e and ankle prostheses for walking and stair ambulation.
22 sors during squats, jumps, walking and stair ambulation.
23 h was reduced in those with an impairment in ambulation.
24 le comparisons of function as it pertains to ambulation.
25 ured in 5 leg muscle locations important for ambulation.
26 omplex environments, restricting their daily ambulation.
27 mes during squats, jumps, walking, and stair ambulation.
28 f onset, and progression leading to impaired ambulation.
29 ioceptive input to maintain stability during ambulation.
30 where their use is associated with prolonged ambulation.
31  facilitating human locomotion in real-world ambulation.
32 ents of PCW in predicting home and community ambulation.
33  threshold of 18-22% associated with loss of ambulation.
34 ive edema and pain in the left leg, limiting ambulation.
35  required ambulation aids or wheelchairs for ambulation.
36 al status, chronic conditions, and prestroke ambulation.
37 lated biomedical sensing abilities including ambulation.
38 accumulate dead calcified myofibers nor lose ambulation.
39 ng instructions for deep breathing and early ambulation.
40  exhibited abnormal anxiety, sociability and ambulation.
41 s effect may also be attributable to earlier ambulation.
42 toperative analgesic requirement and time to ambulation.
43 ism stockings during extended periods of non-ambulation.
44 daily living including a loss of independent ambulation.
45 trogen replacement decreased cocaine-induced ambulations.
46 ng, whereas long-term progesterone decreased ambulations.
47 e p.(Pro209Leu) variant, 10 (62.5%) had lost ambulation, 14 (93.3%) had respiratory insufficiency (11
48 d South Asian participants (n = 18, 41) lost ambulation 2.7 and 2 years earlier than Caucasian subjec
49 r year) alongside functional improvements in ambulation (2.40% [0.29%] per year), bed transferring (3
50 ried from range of motion exercises (81%) to ambulation (22%).
51 ater risk-adjusted likelihood of independent ambulation (42.1% vs 46.6%; AOR, 1.13 [1.08-1.17]; absol
52 nction; (3) cardiac benefits; (4) effects on ambulation; (5) effects on metabolic stress responses; a
53  comorbid conditions were musculoskeletal or ambulation (532 residents [74.2%]), neurologic (505 [70.
54 l intake (4.4 vs 7.3 hours), shorter time to ambulation (6.1 vs 11.5 hours), shorter length of hospit
55            Primary outcomes were independent ambulation (90-day modified Rankin Scale score of 0-3) a
56 s associated with lower rates of independent ambulation (adjusted odds ratio [aOR], 0.44; 95% CI, 0.2
57  disease is rapidly progressive with loss of ambulation after a median of 7 years after disease onset
58 iency (<12 ng/mL) is associated with reduced ambulation after hip fracture surgery, whereas GNRI also
59 r improving patient comfort and accelerating ambulation after invasive cardiovascular procedures perf
60 used for achievement of hemostasis and early ambulation after PCI.
61 e of morbidity and mortality, and successful ambulation after surgery is an important outcome in this
62 s, improved patient comfort, shorter time to ambulation after the procedure, reduced length of hospit
63        Multiple sclerosis patients with poor ambulation (AI > or =7) or severe disability (EDSS >6.5)
64 f the infantile onset patients then required ambulation aids or wheelchairs for ambulation.
65                                      Lack of ambulation and deconditioning effects of bed rest are on
66 y morbid condition that leads to the loss of ambulation and decreased quality of life.
67 is review examines recent in-vivo studies of ambulation and discusses the fundamental role of mechani
68 such as vultures, limb loss leads to loss of ambulation and eventually death from malnutrition.
69 hereas normal poststimulus behaviors such as ambulation and grooming were not displayed as frequently
70 em controller, allowing unrestricted patient ambulation and hospital discharge.
71  other behavioral measures (i.e. spontaneous ambulation and intake) occurred because swim-test resist
72 progressive impaired motor function, loss of ambulation and life-threatening cardiorespiratory compli
73 VR) to target both cognitive aspects of safe ambulation and mobility would lead to fewer falls than w
74 ssion of the odds of preserving prognosis of ambulation and of the effect of therapy on the patient's
75                                  To preserve ambulation and optimize survival, magnetic resonance ima
76 egeneration and weakness, leading to loss of ambulation and premature death from cardiopulmonary fail
77  and flexibility that the skeleton needs for ambulation and protection of vital organs, and the hardn
78 M1 mice in the 3 x 10(11) vg cohort retained ambulation and rearing despite reaching the humane endpo
79 ltiple sclerosis (pwMS) leading to decreased ambulation and reduced walking endurance remain poorly u
80 wasting and weakness, delaying or preventing ambulation and rehabilitation in these patients and incr
81 elationship between kinematic changes during ambulation and the initiation of osteoarthritis at the k
82 projections are bilaterally activated before ambulation and unilateral lever manipulation.
83 oss and fine motor abilities, similar to low ambulation and velocity in AS patients.
84  susceptibility QTL and a QTL for open field ambulation and vertical movement suggests the existence
85 clinical impairment, which was determined at ambulation and with cerebellar and brainstem functional
86                Differences in reported pain, ambulation, and ability to perform ADL before and after
87  sedation, mechanical ventilation, mobility, ambulation, and coordinated care.
88 velopmental delays, muscle necrosis, loss of ambulation, and death.
89  ambulation or resulting in an early loss of ambulation, and demonstrated a cumulative decline in for
90 g prophylaxis, early diet advancement, early ambulation, and early removal of urinary catheter) was i
91 ed oral intake with prokinetic agents, early ambulation, and fixed regimen epidural analgesia.
92  alglucosidase alfa in respiratory function, ambulation, and functional endurance, with no new safety
93 postoperative analgesic requirement, time to ambulation, and length of hospital stay.
94 , as well as for postoperative pain, time of ambulation, and length of hospital stay.
95  2B mutations had the greatest impairment in ambulation, and patients with coil 1A mutations reported
96 the duration of postoperative ileus, time to ambulation, and postoperative analgesic requirement, com
97 nosis, age at wheelchair use, age at loss of ambulation, and presence of cardiomyopathy were analyzed
98    LTBP4 haplotype influences age at loss of ambulation, and should be considered in the management o
99  associated with higher rates of independent ambulation (aOR, 4.95; 95% CI, 2.14-11.43; P < .001), in
100  patients showed a slower rate of decline in ambulation assessed by 6MWT compared to untreated matche
101 ated patients who were IAAM homozygotes lost ambulation at 12.5 +/- 3.3 years compared to 10.7 +/- 2.
102      Secondary outcomes included independent ambulation at 3 months (mRS score 0-3), good functional
103 in 60 days, delirium, time to discharge, and ambulation at 60 days.
104 sia with respect to survival and recovery of ambulation at 60 days.
105 discharge (2.60 [1.67-4.06]) and independent ambulation at discharge (2.40 [1.56-3.70]).
106 ) and less likely to have either independent ambulation at discharge (33.1% versus 37.1%; adjusted od
107 0.05) and a higher likelihood of independent ambulation at discharge (53.3% [468 of 878 patients] vs
108 h higher likelihood of achieving independent ambulation at discharge (absolute increase, 1.14% [95% C
109 0.32-0.84]) and significantly higher odds of ambulation at discharge (aOR, 1.72 [95% CI, 1.37-2.16]),
110  .001), increased achievement of independent ambulation at discharge (OR, 1.04; 95% CI, 1.03-1.05; P
111 TS, with TS phase III showing higher odds of ambulation at discharge among Asian, Black, Hispanic, an
112  hemorrhage, and higher rates of independent ambulation at discharge and discharge to home following
113 omes included discharge to home, independent ambulation at discharge, and functional independence (mo
114 al mortality, discharge to home, independent ambulation at discharge, and length of stay.
115 ons related to tPA use, door-to-needle time, ambulation at discharge, discharge status, and destinati
116 omes were discharge destination, independent ambulation at discharge, modified Rankin score at discha
117 score, 0-1), discharge home, and independent ambulation at discharge.
118 19,491 (33.4%) patients achieved independent ambulation at hospital discharge, and 22,541 (38.6%) pat
119 hronic) that causes kinematic changes during ambulation at the knee to shift the load-bearing contact
120 ale (transfer to chair, marching in place or ambulation away from bed, 122/715 reports).
121  functional measures, such as improvement in ambulation, bathing, and bed transferring.
122 n 30% as independent risk factors for losing ambulation before 18 years of age, in LGMDR3, LGMDR4 and
123 rcent of patients had substantially impaired ambulation before vertebroplasty compared with 28% after
124 ntities 5% (group C), and all but 4 who lost ambulation beyond 24 years of age were ambulant.
125 ties >= 5% (group C), and all but 4 who lost ambulation beyond 24 years of age were ambulant.
126  of care, glucocorticoids, delay the loss of ambulation but increase the risk for insulin resistance
127 luding hindbrain herniation by 12 months and ambulation by 30 months.
128 FKRP/FST gene therapies can overcome loss of ambulation by improving muscle strength at the same time
129 y progressed, leading to loss of independent ambulation by the age of 12.
130 t in adulthood while many UCMD patients lose ambulation by their teenage years and require respirator
131 or V), or severe mobility issues (Functional Ambulation Category <=2).
132 ps in terms of length of stay, postoperative ambulation, Clavien-Dindo graded postoperative complicat
133 et of symptoms and an earlier age of loss of ambulation compared to patients with residual protein ex
134 ore accurately represents home and community ambulation compared to the subjective questionnaire.
135 se that, with hand stereotypies and impaired ambulation, constitute the four core diagnostic features
136 given the gait phase, stair inclination, and ambulation context (transition type, ascent/descent), de
137                Dysfunction of the muscles of ambulation contributes to exercise intolerance in chroni
138                      The rate of independent ambulation decreased from 56.4% in patients aged 60 year
139 netic stimulation in the motor cortex evoked ambulation, deep brain stimulation in the striatum cause
140 mutations displayed intellectual disability, ambulation deficits, severe language impairment, hypoton
141                                Prediction of ambulation depends on a patient's ambulatory status befo
142 ially when combined with early nutrition and ambulation, designed to improve functional recovery and
143 (aggregate score of vision, hearing, speech, ambulation, dexterity, emotion, cognition, and pain), Pa
144 chieved at high rates, whereas others (e.g., ambulation distance), available late in the study period
145 ned spinal-epidural analgesia, which permits ambulation during labor, is associated with a lower inci
146 lgesia, which may have an impact on maternal ambulation during labor.
147 ound in wild-type mice and can induce normal ambulation endurance in a 1-h walk test.
148                                              Ambulation-evaluable eteplirsen-treated patients experie
149 +/- 18%(n = 5); P < 0.05] and maintenance of ambulation (Expanded Disability Status Scale score < 7)
150  of Health Stroke Scale documentation, early ambulation, fall risk assessment, pressure ulcer risk as
151 ges at appearance of first symptoms; loss of ambulation; fall in vital capacity and left ventricular
152 e designed to measure pain (10-point scale), ambulation (five-point scale), and ability to perform ac
153        Nurses who claimed responsibility for ambulation focused on patient independence and psychosoc
154 he functional deficit in manual dexterity or ambulation for the patient.
155 loss of stand from supine, four-stair climb, ambulation, full overhead reach, hand-to-mouth function,
156 emoval by postoperative day 1, and increased ambulation &gt;=3x on postoperative day 1 (PRE 46.8%->POST
157 asured by expanded disability status scale), ambulation (Hauser score), and visual acuity.
158 onists and the benefits and proven safety of ambulation have allowed for outpatient management of mos
159 heparin, enoxaparin once-daily dosing, early ambulation), hospital discharge before initial trough le
160 losure devices have long been used for early ambulation; however, more recent results demonstrating l
161                                              Ambulation improvements in this young population with ea
162                                  Spontaneous ambulation in a novel environment was significantly high
163                Both LSD and efavirenz reduce ambulation in a novel open-field environment.
164 and experienced a lower incidence of loss of ambulation in comparison to matched HC (n = 13) amenable
165 st predictable causes of loss of independent ambulation in hospitalized older persons.
166 ining strategies are available for improving ambulation in individuals with spinal cord injury (SCI).
167  are significantly associated with prolonged ambulation in patients with DMD.
168  like prednisone, are known to delay loss of ambulation in patients with Duchenne muscular dystrophy
169 tomated treadmills were used to induce brief ambulation in rats every 2 min, either prior to, or afte
170 rosthetic-limb control strategies for robust ambulation in real-world settings remain out of reach, p
171 it, including the restoration of independent ambulation in some cases, was observed following deep br
172 re was a correlation between GFAP levels and ambulation in SP multiple sclerosis (r = 0.57, P < 0.01)
173 n showed a Duchenne-like course with loss of ambulation in the early teens while 7 had a milder pheno
174 scusses the fundamental role of mechanics of ambulation in the initiation and progression of osteoart
175 enic mice, we observed significantly altered ambulation in the open field, disrupted motor coordinati
176 th mechanical antiembolism devices and early ambulation in the postoperative period between January 2
177 ams have highlighted the importance of early ambulation in the postoperative period.
178 th mechanical antiembolism devices and early ambulation in the postoperative period.
179         We also determined head pitch during ambulation in the same animals.
180 quent dystrophic calcification, with loss of ambulation in wild-type (WT) mice.
181 )-11 and (-)-12 blocked phencyclidine-evoked ambulations in a dose-dependent manner, indicating their
182 y intensive care unit substantially improved ambulation, independent of the underlying pathophysiolog
183 scale (EDSS) grade (P = .32) or the absolute ambulation index (AI) (P = .20).
184 e Functional Independence Measure (FIM), the Ambulation Index (AI) and the Cambridge Multiple Scleros
185            Disability was assessed using the ambulation index (AI), the Expanded Disability Status Sc
186  patients, SCCSA extensively correlated with Ambulation Index, whereas only the cervical cord correla
187 the Extended Disability Status Scale and the ambulation index.
188  hyperargininemia, spastic diplegia, loss of ambulation, intellectual disability, and seizures.
189 ics in 2 health systems) and 1 evaluating an ambulation intervention (conducted across wards of the H
190                                      Loss of ambulation is common and highly variable in Parkinson's
191 ait-related variables when their velocity of ambulation is tightly controlled by a moving treadmill a
192                                        Human ambulation is typically characterized during steady-stat
193 mes, including amputation, but its effect on ambulation is unknown.
194 0s, but most patients maintained independent ambulation later in life.
195 BP4 and SPP1 polymorphisms on age at loss of ambulation (LoA) in a multiethnic Duchenne muscular dyst
196 ystrophy (DMD), for instance, age at loss of ambulation (LoA) varies between individuals whose DMD mu
197                    The median age at loss of ambulation (LOA) was 13 years (95% CI 12.1 to 13.5); 2 y
198 P rs28357094 in the SPP1 gene and the age of ambulation loss.
199                                       During ambulation, mice carried the lambda-bregma plane at a do
200 res accurate classification of the patient's ambulation mode (eg, on level ground or ascending stairs
201 ormation reduced classification error across ambulation modes and during transitions between ambulati
202 ulation modes and during transitions between ambulation modes.
203 s) and natural transitions between different ambulation modes.
204  dopamine agonists was followed by immediate ambulation, near-complete correction of the movement dis
205 or surgical populations, including those for ambulation, nutrition, and opioid use.
206  ratio, 6.55; 95% CI, 1.17-36.67); dependent ambulation (odds ratio, 7.38; 95% CI, 4.35-13.06) and ha
207 active rehabilitation, physical therapy, and ambulation of patients being managed with extracorporeal
208                                              Ambulation of patients with acute respiratory failure ma
209                         We hypothesized that ambulation of patients with acute respiratory failure wo
210 rses fell into two groups: those who claimed ambulation of patients within their responsibility of pr
211           At the later stages of the disease ambulation often becomes difficult, with owners often el
212 ether powered prostheses can restore natural ambulation on stairs for bilateral above knee individual
213 t failed to alter exploratory-like behavior (ambulation or rearing).
214  by severe muscle weakness either preventing ambulation or resulting in an early loss of ambulation,
215 most patients have muscle hypotonia, delayed ambulation, or kyphosis, pointing to an underlying skele
216 ctronic detection of external markers during ambulation over a multicomponent force plate, and were m
217 t substantially increased the probability of ambulation (p < .0001).
218  clinical outcomes, including age at loss of ambulation (p < 0.001).
219 progression was observed for NNSS domains of ambulation (p=0.0622), cognition (p=0.0040) and speech (
220  16 modulated 5-HT(2C)R-mediated spontaneous ambulation, partially substituted for the training dose
221 ocampal SD is sufficient to elicit postictal ambulation (PIA), whereas induced isolated seizure-like
222 ression, or the use of assistive devices for ambulation predicted poorer outcomes in homebound older
223               All participants received safe ambulation recommendations.
224 the ICU, improved pain management, and early ambulation reduce length of stay, with 50% in group II d
225 ment Scale grade and Frankel grade) and poor ambulation, reduced performance status, and systemic dis
226              The AI was a reliable and valid ambulation-related disability scale, but it was weakly r
227 that cadence-based measures, gait speed, and ambulation-related signal perturbations were distinct ch
228                               However, stair ambulation requires different kinematics, kinetics, and
229 e bleeding complications are less, and early ambulation results in a shorter hospital length of stay.
230 , 95% CI 1.39 to 2.07; I(2)=0%), independent ambulation (risk ratio (RR) 1.69, 95% CI 1.33 to 2.14; I
231 o achieve reasonable performance for loss of ambulation (ROC-AUC score of 0.83).
232  included the numbers of participants losing ambulation; scoring >= 3 on UMSARS part I items for fall
233        In particular, chair use has replaced ambulation, so that obese individuals tend to sit for ap
234 for dystrophin production, also resulting in ambulation stability.
235 ed with autonomic symptoms, autonomic tests, ambulation status, and progression of disability.
236 ic symptoms, nutritional status, disability, ambulation status, motor function, and cardiac stress, w
237 t failure; and poor (<0.36) for dysrhythmia, ambulation status, pericarditis, chronic obstructive pul
238 secondary efficacy end point was independent ambulation status.
239           It was more pronounced for forward ambulation than for rearing, with no augmented response
240 ased anxiety, poor motor learning, excessive ambulation that is eliminated by very low levels of nico
241  increase in the amount of nocturnal forward ambulation that persisted long after cessation of drug t
242 ernal care and non-specific behavior such as ambulation time, self-grooming, and inactivity.
243          Postoperative pain, nausea, time to ambulation, time to first passage of flatus/stool, lengt
244 sibility deferred decisions about initiating ambulation to either physical therapy or medicine.
245 hat is relevant to joint motions from normal ambulation to high-frequency impact loading.
246 h patient mortality and morbidity, including ambulation, toileting, and cognition.
247 essation trial and $0, $100, or $300 for the ambulation trial.
248 and 5 multiracial individuals [0.8%]) in the ambulation trial.
249  did not increase consent among those in the ambulation trial: 98 of 216 (45.4%), 102 of 212 (48.1%),
250 al and January 2018 through May 2019 for the ambulation trial; data were analyzed from January 2020 t
251  approximately equal components derived from ambulation, vestibular, and optic-flow signals.
252  of a normal diet was 0.58 days +/- 0.56, to ambulation was 1.22 days +/- 0.77, and to discharge from
253                           The median loss of ambulation was 12 years in intermittent and 14.5 years i
254                  Average time from injury to ambulation was 2 days less in the surgical group, but no
255              The dressings were removed, and ambulation was encouraged 5 h after sheath removal.
256 eak frequency of the HPC theta rhythm during ambulation was higher in NP rats (7.62 +/- 0.12 Hz) as c
257         Because of slow disease progression, ambulation was largely preserved.
258                               Improvement in ambulation was measured using T25FW responder status; re
259 t a high adduction moment at the knee during ambulation was most frequently reported to influence the
260               The primary outcome (community ambulation) was defined as walking 300 m or more in 6 mi
261 core (range, 1 [bedbound] through 10 [normal ambulation]) was assessed before and after AORIF at 2 we
262 ons (77.8%), while pregait physiotherapy and ambulation were only sometimes or infrequently (70.4%) u
263 ss index (BMI; in kg/m(2)) z score, age, and ambulation were positive predictors of BMC, which declin
264 is idea, we observed a decrease in off-wheel ambulation when mice were using the wheels, indicating b
265 heart replacement therapies while preserving ambulation when used with a transaxillary approach.
266 D) most frequently presents with pain during ambulation, which is known as "intermittent claudication
267 ombined with weakness precluding independent ambulation, while the patient with the de novo missense
268 ent stepping in parallel bars and overground ambulation with a walker.
269                                              Ambulation with existing prostheses is extremely difficu
270                              Improvements in ambulation with transfer to the respiratory intensive ca
271 his provided robust and intuitive control of ambulation--with seamless transitions between walking on
272                 All patients were capable of ambulation within their home and community using a passi

 
Page Top